Plasmalogens are a major class of ethanolamine and choline phospholipids in which the sn -1 position of the glycerol backbone has a long chain fatty alcohol attached through a vinyl ether bond (1) . They constitute 18% of total phospholipid mass in humans, with the highest amounts in heart, striated muscle, and nervous tissue (2) . In the Chinese hamster ovary (CHO) cell line, 11% of the total phospholipids are plasmalogens, primarily ethanolamine plasmalogen, called plasmenylethanolamine (PlsEtn) (3) . CHO cells do not contain plasmenylcholine (4) . The cellular distribution of plasmalogens has not been thoroughly characterized, although they are reportedly present in plasma membrane (5) , synaptic vesicles (6) , and secretory granules (7) . In erythrocytes, plasmalogens are found to be oriented with the same asymmetric distribution as their diacyl analogs (8) .
For such an abundant phospholipid, plasmalogen functions are quite obscure. Current in vitro models suggest that PlsEtn plays a role in membrane fusion-mediated events (9) and protects against reactive oxygen species (10). In this study, we investigated the role of PlsEtn in cholesterol metabolism, prompted by the finding that cholesterol efflux to HDL is aberrant in plasmalogen-deficient RAW mutant macrophages (11) . The lack of plasmalogens did not alter the rate of cellular cholesterol transfer to HDL; instead, it appeared to reduce the pool of cholesterol available for efflux. Another study showed that levels of PlsEtn are reduced in brain tissue from the Niemann-Pick C (NPC) mouse model (12) . NPC cells exhibit lysosomal storage of cholesterol, gangliosides, and other lipids, as well as aberrant cholesterol homeostatic responses (13) . If plasmalogens affect the cellular cholesterol distribution, then reduced plasmalogen levels might exacerbate the cholesterol transport defective phenotype of NPC and contribute to disease progression.
Our model systems were CHO cell mutants NRel-4 and NZel-1, which display greatly reduced levels of PlsEtn due to defects in different steps of plasmalogen biosynthesis (3, 14) . NRel-4 has a defect in dihydroxyacetonephosphate acyltransferase (DHAPAT) (3), the enzyme that cat-alyzes the first step in plasmalogen biosynthesis. NZel-1 has a defect in alkyl-dihydroxyacetone phosphate (DHAP) synthase (14) , which catalyzes the second step in plasmalogen biosynthesis.
Our analysis revealed that PlsEtn is essential for specific cholesterol transport pathways. In PlsEtn deficient cells, the movement of cholesterol from endocytic compartments or the plasma membrane to ACAT in the endoplasmic reticulum (ER) was deficient. Cholesterol movement to the plasma membrane appeared to be normal, as did vesicular protein trafficking. Defective cholesterol transport pathways were restored in NRel-4 cells transfected with a cDNA encoding the missing enzyme, DHAPAT, or supplied with an intermediate that enters the PlsEtn biosynthetic pathway downstream of the metabolic defect. These data support a role for PlsEtn in specific cholesterol transport pathways, those from the cell surface to the cell interior. [9, H]CO-LDL) was prepared with an average specific activity of 38,000 dpm/nmol of total cholesteryl ester (16) . 125 I-LDL was prepared by the iodine monochloride method (15) . Lipoprotein-deficient serum (LPDS) was prepared as described, omitting the thrombin incubation (15) . The following media were prepared: H-5% newborn calf serum (NCS) and H-10% NCS (Ham's F-12 medium containing 5% or 10% (v/v) newborn calf serum, 2 mM glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, and 20 mM HEPES, pH 7.1); H-5% LPDS and H-1% LPDS [H-5% NCS in which 5% (v/v) newborn calf serum was replaced with 5 or 1% (v/v) lipoprotein-deficient calf serum, respectively]; H-5% LPDS/mev (H-5% LPDS containing 20 M mevinolin and 0.5 mM mevalonate).
EXPERIMENTAL PROCEDURES

Materials
The following buffers were prepared: TBS (50 mM Tris-Cl and 155 mM NaCl, pH 7.4) and PBS (1.5 mM KH 2 HPO 4 , 2.7 mM KCl, and 137 mM NaCl, pH 7.3).
All cells were grown as monolayers in a humidified incubator (5% CO 2 ) at 37 Њ C in H-5% NCS. The mutant cell lines, NRel-4 (3) and NZel-1 (14), were isolated as described previously. NRel-4 and NZel-1 cells display deficiencies in DHAPAT and alkyl-DHAP synthase, respectively. Both show a 90% loss in PlsEtn levels compared with wild-type cells. NRel-4.15 is a clonal isolate, stably expressing human DHAPAT cDNA (kindly provided by Wilhelm Just, Univ. Heidelberg, and directionally inserted into the pBK-CMV expression vector; Stratagene) and containing wild-type plasmalogen levels. NRel-4.CMV has been transfected with vector alone and is plasmalogen-deficient (Zoeller et al., unpublished observations). CHO mutant 2-2 was isolated by Dahl et al. (17) and has the NPC phenotype. On day 0 of each experiment, monolayer stock flasks of CHO-K1 and mutant cells were trypsinized, and cells were seeded as indicated in the individual experiment.
Incorporation of [ 3 H]oleate into cholesteryl [ 3 H]oleate
On day 0, cells were seeded into 6-well plates (20, 
ACAT assay in cell-free extracts
On day 0, cells were seeded in 100-mm dishes (300-500,000 cells/dish) in H-5% NCS. Cells were cultured until 80% confluent, with media changes every 2 days. On the day of assay, cells were refed 10 ml/dish H-5% NCS. After 2 h, cells were washed with PBS, subjected to hypotonic shock, and scraped as described (20) . Aliquots of 150 l with ‫ف‬ 200-250 g cell protein were used per assay reaction. The reaction was initiated by the addition of 20 l of [ 14 C]oleoyl-CoA (15 nmol; 30,000 dpm/nmol) containing 300 g of BSA in 125 mM Tris-HCL, pH 7.8. Assays were carried out at 37 Њ C for 3-15 min. Lipids were extracted and analyzed by TLC on silica gel 60 plates as described (21) .
LDL receptor activity, and the esterification of LDL-derived [ 3 H]cholesterol
On day 0, cells were seeded into 6-well plates (25,000 cells/well) in H-5% NCS. On day 2, cells were fed H-5% NCS. On day 3, cells were washed in HBSS and fed H-5% LPDS. On day 4, cells were incubated for 6 h with either 125 I-LDL or [ 3 H]CL-LDL. The uptake and proteolytic degradation of 125 I-LDL was measured by incubating cells with 20 g/ml 125 I-LDL in the absence and presence of 500 g/ml of unlabeled LDL. After 6 h, the release of 125 I-monoiodotyrosine was quantified as described (15 (22) . The amount of LDL-derived [ 3 H]cholesterol that was re-esterified by ACAT to form cholesteryl [ 3 H]oleate was also quantified as described previously (22) .
Filipin fluorescence microscopy
On day 0, cells were seeded in 4-well Falcon 4104 chamber slides (1,500 cells/well) in H-5% NCS. On day 2, cells were refed. On day 3, cells were washed with PBS and processed for filipin fluorescence microscopy as described (23) .
by guest, on September 29, 2016 www.jlr.org
Downloaded from
Cholesterol oxidase treatment
On day 0, cells were seeded into 6-well plates (25, 
Amphotericin B killing
On day 0, cells were seeded in 96-well plates (15,000 cells/ well) in H-5% NCS. On day 1, cells were fed H-5% LPDS. On day 2, cells were fed H-5% LPDS/mev. After 8 h, cells were fed H-5% LPDS/mev with indicated additions of LDL. On day 3, cells were incubated 5 h in H-1% LPDS with or without 100 g/ml amphotericin B. After 5 h, cells were washed with HBSS. Cell viability was assessed using a colorimetric 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay as described (22) . Cell survival is defined as the mean MTT cleaved (A 560 ) per well from three wells treated with amphotericin B expressed as a percentage of the mean MTT cleaved (A 560 ) per well from three wells not treated with amphotericin B.
Basal esterification of plasma membrane cholesterol
Cholesterol content
On day 0, cells were seeded into 100-mm dishes (100,000 cells/dish) in H-5% NCS. On day 2, cells were washed with HBSS and fed H-5% NCS or H-5% LPDS. On day 4, cells were washed with TBS. Lipids were extracted and quantified as previously described (23) , except that each sample consisted of one 100-mm dish. Gas chromatography was conducted isothermally using a DB-17 capillary column (15 m ϫ 0.53 mm, Alltech) at 245 Њ C.
Secretion of newly-synthesized proteins to the medium
Method 1. On day 0, cells were seeded in 6-well plates (50,000 cells/well) in H-5% NCS. On day 1, cells were refed 1 ml of Dulbecco's Modified Eagle Medium (no methionine, no cysteine) containing 10 mM ammonium chloride and 50 Ci EasyTag Express 35 S. At staggered times, the media were removed and centrifuged, and subjected to TCA precipitation. The pellets were dissolved in 0.5 N NaOH and subjected to liquid scintillation counting.
Method 2. On day 0, cells were seeded in 24-well plates (12,000 cells/well) in H-5% NCS. On day 1, cells were refed H-10% NCS with and without 20 M 1-monopalmityl glyceryl ether (Doosan Serdary Research Laboratories). This compound is readily taken into cells, entering the pathway downstream of DHAPAT and alkyl-DHAP synthase. Incubation with this substrate over a period of 2-3 days restores PlsEtn levels to normal in NRel-4 cells (3). On day 4, cells were refed 200 l of Dulbecco's Modified Eagle Medium (no methionine, no cysteine) after which staggered additions of EasyTag Express 35 S were made (50 Ci/well). At time of harvest, the media were removed and centrifuged. Aliquots were subjected to 12% SDS-PAGE, after which gels were fixed, impregnated with Autofluor (National Diagnostics), and exposed to film. Densitometric analysis was performed using an AlphaImager 2200.
Fluid-phase endocytosis and clearance of [ 14 C]sucrose
To measure endocytosis, on day 0, cells were seeded into 6-well dishes (50,000 cells/dish) in H-5% NCS. On day 1, cells were refed H-10% NCS with and without 20 M 1-monopalmityl glyceryl ether. On day 4, [ 14 C]sucrose (260 Ci) was dried under nitrogen at 37 Њ C and dissolved in 260 l water. Cells were refed 1 ml of H-5% NCS after which staggered additions of 10 Ci [ 14 C]sucrose were made. At time of harvest, cells were washed with TBS containing 2 mg/ml BSA (once quickly, then six times, 3 min each), then with TBS (once quickly, then 5 min). Cells were solubilized with 1 ml 1% SDS for 30 min. Aliquots of the cell extract were subjected to liquid scintillation counting in 10 ml of ReadySafe and protein determination (19) .
To measure clearance of endocytosed [ 14 C]sucrose, on day 0, cells were seeded in 6-well plates (25,000 cells/well) in H-5% NCS. On day 2, cells were refed H-5% NCS. [ 14 C]sucrose was dried under nitrogen at 37 Њ C, dissolved in water, added to H-5% NCS, and stored at 4 Њ C overnight. On day 3, cells were refed 0.5 ml H-5% NCS containing 70-200 Ci [ 14 C]sucrose. After 3 h, cells were washed six times with H-5% NCS and refed 1 ml H-5% NCS. At the indicated time, the media were removed and subjected to centrifugation (15,000 g , 5 min). Cells were washed with TBS containing 2 mg/ml BSA (once quickly, then 5 min), then with TBS (once quickly, then 5 min). Cells were solubilized with 1 ml 1% SDS for 30 min. Aliquots of media and cell extract were subjected to liquid scintillation counting in 10 ml of ReadySafe.
RESULTS
Plasmalogen biosynthesis
Plasmalogen synthesis begins in peroxisomes, where DHA-PAT catalyzes the formation of acyl-DHAP (25) ( Fig. 1 ) . Alkyl-DHAP synthase catalyzes the second step in the pathway, forming the ether bond to produce alkyl-DHAP. Plasmalogen synthesis then continues in the ER. NRel-4 and NZel-1 cells are independently isolated CHO cell mutants defective in DHAPAT and alkyl-DHAP synthase, respectively (3, 14) . Unlike other plasmalogen-deficient mutants (26, 27) , NRel-4 and NZel-1 have single enzyme defects and intact functional peroxisomes (3, 14) . These cells make excellent model systems in which to study the relationship between plasmalogen and cholesterol metabolism. We were interested in investigating this relationship because of the apparent effect of plasmalogens on the pool of cellular cholesterol available for efflux to HDL (11) . If plasmalogens play a role in membrane fission and fusion (9), a PlsEtn deficiency may alter cholesterol transport pathways throughout the cell.
Stimulation of cholesterol esterification by LDL and 25-hydroxycholesterol
ACAT is a resident ER enzyme (28) that catalyzes cholesterol esterification. ACAT activity is low when the ER cholesterol content is low and the enzyme is allosterically activated by cholesterol (29) . The ability of LDL to stimulate ACAT activity depends on LDL receptor activity, hydrolysis of LDL's cholesteryl esters, and transport of LDLderived cholesterol from lysosomes to the ER. nmol/h/mg). When LDL was added, cholesterol esterification was stimulated in a concentration-dependent manner such that 50 g/ml LDL increased cholesterol esterification 6-fold. Mutant NRel-4 and NZel-1 cells also exhibited low rates of cholesterol esterification in the absence of LDL (1.1 and 0.9 nmol/h/mg, respectively); however, LDL stimulated cholesterol esterification only 3-fold and 2-fold, respectively. 25-Hydroxycholesterol stimulated cholesterol esterification equivalently in all cell lines, suggesting that ACAT is not defective in the mutant lines. Furthermore, in vitro ACAT activity was equivalent in CHO and NRel-4 cells at 7.97 Ϯ 2.18 and 7.14 Ϯ 0.8 pmol cholesteryl [ 14 C]oleate formed/min/mg protein, respectively (n ϭ 3 experiments).
Is the blunted response to LDL due to a lack of PlsEtn? 
LDL receptor activity and lysosomal storage of LDL-cholesterol
Defective LDL stimulation of cholesterol esterification could be explained by reduced LDL receptor activity or reduced hydrolysis of LDL-derived cholesteryl esters in lysosomes. We measured LDL receptor activity using 125 I-LDL as a LDL receptor ligand. CHO and NRel-4 cells were incubated for 6 h with 20 g/ml 125 I-LDL and the amount of 125 I-LDL internalized and degraded was determined. Table 1 shows that the percentage of LDL cholesteryl esters hydrolyzed was the same in both cell types. This result indicates that defective LDL stimulation of cholesterol esterification in the mutant line is not a result of the mutant's inability to obtain free cholesterol from LDL.
Defective LDL stimulation of cholesterol esterification could also be explained by aberrant lysosomal sequestration of LDL-derived cholesterol, as is seen in NPC fibroblasts (30) . Possible lysosomal storage of LDL-cholesterol (LDL-C) was assessed by culturing CHO and NRel-4 cells in LDL-containing medium, then examining filipin-stained cells by fluorescence microscopy. Filipin is a fluorescent polyene antibiotic that binds specifically to cholesterol and is used to detect cellular cholesterol pools. Wild-type CHO cells exhibited filipin staining at the plasma membrane and in a punctate distribution, most likely representing endosomes and lysosomes (Fig. 4) . NRel-4 cells were indistinguishable from control cells, whereas CHO mutant 2-2 with the NPC phenotype (17) showed the characteristic lysosomal storage of free cholesterol.
These results indicated that reduced LDL-stimulation of cholesterol esterification was not due to lysosomal sequestration of LDL-C, but must result from defective postlysosomal cholesterol transport to the ER. Thus, we next examined pathways of cholesterol transport in the plasmalogen-deficient mutant NRel-4.
Movement of LDL-derived cholesterol from lysosomes to the plasma membrane
The bulk of LDL-C that exits lysosomes is transported to the plasma membrane (31) . This pathway was assessed using two approaches. First, the movement of LDL-derived [ 3 H]cholesterol to a cholesterol oxidase-sensitive pool was measured. Cells were incubated for 4 h with [ 3 H]CO-LDL, then treated with cholesterol oxidase using conditions under which only plasma membrane cholesterol is oxidized (22, 32) . LDL-derived [ 3 H]cholesterol that has been transported to the plasma membrane will be oxidized to [ 3 H]cholestenone. Table 2 shows that similar amounts of LDL-C were accessible to cholesterol oxidase in CHO and NRel-4 cells. In contrast, the NPC1-deficient mutant 2-2 showed significantly less [ 3 H]cholestenone formation, consistent with [ 3 H]cholesterol sequestration in lysosomes.
The second approach used to measure cholesterol transport along this pathway was to examine LDL-dependent amphotericin B killing of parental and mutant cells. Amphotericin B is a polyene antibiotic that forms aqueous pores in cholesterol-rich membranes (33) (34) (35) . Cells grown in conditions under which the plasma membrane is rich in synthesized or LDL-derived cholesterol are killed by amphotericin B. Figure 5 illustrates LDL-dependent amphotericin B killing of CHO and NRel-4 cells. In this experiment, cells were incubated in media containing various concentrations of LDL for 16 h and treated with amphotericin B for 5 h. Cell survival was assessed using a colorimetric MTT assay. When cells were grown in H-5% NCS or H-5% LPDS, cell survival was low in both cell lines due to the arrival of endogenously synthesized cholesterol in the plasma membrane (data not shown). Cells cultured in H-5% LPDS/mev survived amphotericin B treatment because endogenous cholesterol synthesis was blocked by mevinolin. The addition of LDL caused concentrationdependent killing that was equivalent in both cell lines. This result further supports the idea that transport of cholesterol from lysosomes to the plasma membrane is normal in NRel-4 cells.
Movement of LDL-derived cholesterol from lysosomes to ER
Approximately 30% of LDL-C that exits lysosomes is transported to ACAT in the ER by a pathway that is independent of the plasma membrane (22, 31 (36) . In this experiment, LDL receptor activity was equivalent in the two cell lines. Figure 6A shows the cellular content of [ 3 H]cholesterol after 6 h in the indicated amount of [ 3 H]CL-LDL. However, the amount of LDL-C that was transported to ACAT and re-esterified to cholesteryl oleate in NRel-4 cells was significantly reduced, at 63% of control levels (Fig. 6 B) . 
Plasma membrane to ER cholesterol transport
We evaluated basal cholesterol movement from the plasma membrane to the ER by incubating the cells for various times with [ 3 H]cholesterol (22) . As seen in Fig. 7 , CHO cells showed a time-dependent incorporation of 
Movement of newly-synthesized cholesterol to the plasma membrane
We evaluated the transport of newly-synthesized cholesterol from the ER to the plasma membrane by pulse-labeling cells for various times in [ 3 H]acetate. [ 3 H]cholesterol arrival in the plasma membrane was assessed using two approaches. First, we quantified the amount of [ 3 H]cholesterol capable of effluxing to cyclodextrins in the media (Fig. 8A, B) . Throughout the time course, CHO cells effluxed 37 Ϯ 5.6% of newly synthesized [ 3 H]cholesterol, whereas NRel-4 cells effluxed 45 Ϯ 6.5%. Second, we quantified the amount of newly synthesized cholesterol that is accessible to cholesterol oxidase (Fig. 8C, D 
Cellular cholesterol content
Our hypothesis is that the reduced LDL stimulation of esterification is the result of a reduced capacity of NRel-4 cells to transport cholesterol to ACAT in the ER. If this is correct, then the free cholesterol content of NRel-4 cells should be normal, but the cholesteryl ester content should be reduced. An alternative explanation is that NRel-4 cells have a lower cholesterol content than normal cells, and [ 3 H]cholesterol fills the depleted plasma membrane pool rather than moving to the ER. Thus, we have measured by gas-liquid chromatography the cholesterol and cholesteryl ester contents of CHO and NRel-4 cells that were cultured in H-5% NCS or H-5% LPDS ( Table 3) . CHO and NRel-4 cells grown in H-5% LPDS had similar cholesterol and cholesteryl ester contents. Growth in lipoprotein-containing H-5% NCS caused an equivalent increase in free cholesterol in both cell lines; however, there was a significantly higher increase in cholesteryl ester content in CHO cells compared with NRel-4 cells. This result is consistent with the LDL stimulation of cholesterol ester- ification shown in Fig. 2 and provides evidence that the lowered basal esterification is a result of a pathway defect rather than a lack of cholesterol available to move along that pathway.
Secretion of newly synthesized proteins to the medium
The cholesterol transport pathways that are affected by the lack of plasmalogens are vesicular pathways, based on the effects of pharmacological agents (37) . Does the lack of PlsEtn reduce the flow of cholesterol along those transport pathways because they require efficient membrane fission and fusion? If so, then other vesicular transport pathways should be affected. Vesicular transport of proteins was compared in CHO and NRel-4 cells, and in NRel-4 cells and NRel-4 cells cultured for 2 days with 1-monopalmityl glyceryl ether, which enters the PlsEtn biosynthetic pathway downstream of the NRel-4 defect and restores plasmalogen levels to normal (3). Cells were radiolabeled for various times with [ 35 S]methionine and the arrival of newly synthesized and secreted proteins in the medium was assessed either by TCA precipitation of proteins followed by liquid scintillation counting, or by gel electrophoresis and fluorography. The incorporation of [ 35 S]methionine into cellular proteins was equivalent in CHO cells and NRel-4 cells cultured with and without 1-monopalmityl glyceryl ether (data not shown). Furthermore, the secretion of newly synthesized proteins was equivalent in CHO and NRel-4 cells (Fig. 9A) . Figure 9B shows the comparison of proteins secreted from NRel-4 cells cultured with and without 1-monopalmityl glyceryl ether. There is a discernable increase in the secretion of newly synthesized proteins from NRel-4 cells supplemented with 1-monopalmityl glyceryl ether, as compared with unsupplemented cells. Densitometric analysis of two bands revealed a mean increase of 30%, indicating that the vesicular protein secretion pathway is partially dependent on PlsEtn.
Fluid-phase endocytosis and exocytosis
We used [ 14 C]sucrose as a fluid-phase marker to test if endocytosis is affected by the PlsEtn deficiency (Fig. 10A) . We found that levels of cell-associated [ 14 C]sucrose increased linearly with time in both control and NRel-4 cells. The rate of [ 14 C]sucrose accumulation in NRel-4 cells was less that of control; however, this difference was not corrected by restoration of PlsEtn levels. This indicates that the variation in endocytosis is not due to altered PlsEtn levels. Fluid-phase exocytosis was assessed by allowing cells to internalize [ 14 C]sucrose then quantifying its retrograde transport from endocytic compartments to the medium (38) . Figure 10B shows that the clearance of [ 14 C]sucrose from control and NRel-4 cells was equivalent. This result indicates that exocytosis is also PlsEtn independent. 
DISCUSSION
Our work on plasmalogen's role in cholesterol transport was prompted by two recent findings. First, Mandel et al. (11) reported an effect of plasmalogens on HDLmediated cholesterol efflux. Normal and plasmalogendeficient murine macrophage-like RAW cells were labeled with [ 3 H]cholesterol, and then [ 3 H]cholesterol efflux to HDL was measured. They found that HDL-mediated cholesterol efflux was reduced in the plasmalogen-deficient lines in comparison to the normal cell lines, which would be consistent with a plasmalogen effect on the pool of cellular cholesterol available for efflux to HDL. Specifically, they observed that the maximal amount of cholesterol transferred was altered, whereas the rate of cholesterol efflux was unaffected by the lack of plasmalogens.
Second was a report that plasmalogen levels were reduced in brain tissue from the NPC mouse model (12) , which likely results from the impaired peroxisomal function found in NPC brain. The NPC1 gene defect results in reduced transport of cholesterol, glycosphingolipids, and fluid phase constituents out of lysosomes and late endosomes (38, 39) . It is not clear how an NPC1 defect leads to loss of peroxisomal activities, but the subsequent plasmalogen deficiency may further impair cellular cholesterol movement and be a contributing factor in NPC disease progression.
In this study, we found that two independently isolated CHO mutants bearing different lesions in the plasmalogen biosynthetic pathway displayed a decreased ability to transport LDL-derived or plasma membrane cholesterol to ACAT in the ER. The phenotype of DHAPAT-defective NRel-4 cells could be completely reversed by recovery of plasmalogen levels in these cells following transfection with the DHAPAT gene. The phenotype is not due to a requirement for PlsEtn in ACAT's lipid milieu, since ACAT was activated to normal levels by 25-hydroxycholesterol. Oxysterols, such as 25-hydroxycholesterol, diffuse readily throughout the cell and activate ACAT independently of specific cholesterol transport mechanisms. Normal 25-hydroxycholesterol stimulation of cholesterol esterification indicated that ACAT was normal in the mutant cells and that delivery of surrounding substrate is not an issue. Furthermore, the lack of LDL-stimulation of cholesterol esterification was not the result of reduced LDL receptor activity or lysosomal hydrolysis of LDL-cholesteryl ester, or aberrant lysosomal storage of cholesterol. Instead, it is likely due to reduced trafficking of cholesterol from lysosomes and plasma membrane to the ER (22, 37) . Other cholesterol transport steps were normal in PlsEtn-deficient cells, as was protein secretion and fluid phase endocytosis and exocytosis.
The PlsEtn-deficient phenotype closely resembled that of CHO mutant 3-6, which was isolated in our hunt for NPC-like mutant CHO cells (23) . The 3-6 mutation also causes defective mobilization of cholesterol from the plasma membrane to the ER but does not affect other cholesterol transport pathways. 25-Hydroxycholesterol stimulation of ACAT was normal in mutant 3-6, as it was in PlsEtn-deficient cells. However, our work also showed that the PlsEtn-deficient phenotype was clearly distinct from the 3-6 phenotype. Mutant 3-6 cells have normal PlsEtn levels (data not shown). They are resistant to amphotericin B when supplied with endogenously synthesized cholesterol, LDL, or cholesterol sulfate (23) , whereas the PlsEtn-deficient cells were amphotericin B sensitive under those conditions.
Our current results are not in agreement with Thai et al. (40) , who found impaired membrane traffic in plasmalogendeficient cells. They interpreted collagen accumulation in DHAPAT-deficient cells as indicating impaired transit of proteins through the trans Golgi network, whereas we found normal secretion of nascent proteins. They also reported cholesterol accumulation in late endosomal/lysosomal compartments of mutant cells, as measured by filipin fluorescence microscopy, whereas we found no discernable cholesterol accumulation. They also found diminished transferrin uptake and structurally altered caveolae and coated pits. We have not measured transferrin uptake but did find normal LDL internalization. Some of these differences may be due to the different cell models examined, i.e., human fibroblasts versus CHO cells. Other differences may not be related to the plasmalogen deficiency. Thai et al. (40) do not report the effect of restoration of plasmalogen levels on any of the phenotypic changes.
Mandel et al. (11) found diminished cholesterol efflux from plasmalogen-deficient murine RAW macrophages and human skin fibroblasts to the extracellular acceptor HDL, whereas we found no effect of plasmalogens on the movement of newly synthesized [ 3 H]sterol to the plasma membrane and efflux to cyclodextrin. The inconsistency between our results and those of Mandel et al. (11) likely arise from the different methods used to measure this process. Cyclodextrins have been shown to have a much higher efficiency in stimulating cholesterol efflux than HDL (41) , and the cyclodextrin-accessible pool of cholesterol is likely to be different than the HDL accessible pool.
The question that we now face is what role does PlsEtn play in cholesterol movement to ACAT? Studies of plasmalogens in intact cells (10) and model systems (42) have shown that they have a role in protecting cells from oxidative damage. Plasmalogens are also thought to serve as sources of lipid mediators, such as arachidonic acid, that are involved in signal transduction (43) . In addition, when PlsEtn is hydrolyzed by the plasmalogen-selective PLA 2 , the lysoplasmalogen generated from the reaction can induce the synthesis of platelet-activating factor (44) . However, it is difficult to rationalize how these putative functions would relate to cholesterol transport.
Another characteristic of PlsEtn is their ability to form non-bilayer structures. Studies of model membrane systems have shown that, like phosphatidylethanolamine, PlsEtn is a nonbilayer-forming phospholipid. However, the phase behavior of PlsEtn differs markedly from the related alkylacyl and diacyl species, with a liquid crystalline to inverse hexagonal transition temperature for the three species at 30ЊC, 53ЊC, and 68ЊC, respectively (9) . Therefore, PlsEtn is the only one of these phospholipid species to form non-bilayer structures at or below physiological temperatures. The vinyl ether bond causes PlsEtn to form a hexagonal array more readily than phosphatidyl-ethanolamine and, thus, they are hypothesized to play a role in membrane fission and fusion events (9, 45) . In support of this, Glaser and Gross (45) showed that PlsEtn stimulated the kinetics of in vitro membrane fusion 6-fold when vesicles of physiologic phospholipid composition were compared with those in which PlsEtn was replaced with phosphatidylethanolamine. Does the PlsEtn deficiency in NRel-4 cells affect membrane fission or fusion? Our data are not consistent with this hypothesis as vesicle trafficking was normal by all criteria examined.
Future work must determine the precise role that plasmalogens have in this specific cholesterol transport pathway. We have not ruled out the idea that it is a product of phospholipase A 2 hydrolysis of PlsEtn rather than PlsEtn itself that is needed for cholesterol transport. The availability of the plasmalogen-deficient cell lines and our ability to modulate plasmalogen levels in those cells will allow us to examine and answer plasmalogen's role in cholesterol transport.
